Skip to main content
OpenTrials
Completed

NCT Number: NCT06118125

Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement

Objective: the pre-hospital management of cancers is little known in General Medicine. The first lockdown related to the COVID-19 pandemic led to the closure of health facilities. Investigators were interested in the diagnosis and care pathway of digestive cancers in post-confinement in General Medicine in Nouvelle-Aquitaine.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Method: patient records discussed in Digestive Oncology CPR of Bordeaux University Hospital for the first time from June 1 to August 31, 2020 and over the same period in 2019 were included. A questionnaire on the dates of the first symptoms, first consultation with the general practitioner, imaging examination and access to the specialist was sent to the general practitioner. The primary outcome was time from onset to date of first MDT.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • residing in New Aquitaine and
  • whose general practitioner practiced in New Aquitaine
  • malignant tumors of the esophagus, stomach, small intestine, colon, recto-sigmoid junction, rectum, anus and anal canal, liver and intrahepatic bile ducts, extrahepatic bile ducts, gallbladder and pancreas.
  • to have had at least one consultation or hospitalization in the digestive pole of the Bordeaux University Hospital within 6 months after the MDT.

Exclusion criteria

  • Patients under 18 years of age,
  • who had already had a MDT for this cancer,
  • whose date of first MDT was outside the inclusion dates,
  • whose new cancer was a digestive metastasis of a primary of another location,
  • who did not have French health insurance

Treatment and study plan

Primary outcomes

  1. time from date of first symptoms of cancer to the date of first MDT

    Time frame: DAYS

    time from date of first symptoms of cancer to the date of first MDT

Secondary outcomes

  1. time from date of first symptoms to date of first consultation with a general practitioner,

    Time frame: DAYS

    time from date of first symptoms to date of first consultation with a general practitioner,

  2. time from date of first symptoms to first imaging or specific examination,

    Time frame: DAYS

    difficulties in referral to imaging,

  3. time from date of first symptoms to consultation with a specialist,

    Time frame: DAYS

    difficulties in referral to a specialist,

  4. stage of pathology by type of cancer,

    Time frame: at inclusion

    stage of pathology by type of cancer according to TNM classification (tumor, node, metastatic status)

  5. frequency of different types of cancer,

    Time frame: at inclusion

    PERCENTAGE of each type of cancers in this study

  6. overall survival.

    Time frame: MONTHS, time from from date of first symptoms to date of death

    overall survival.

Sponsors and collaborators

Lead sponsor

University of Bordeaux

Other

Registry information

Official study title

Delay to Diagnosis and Management in Digestive Cancerology by the General Practitioner Within the City-hospital Network in the Context of Confinement Related to the Covid-19 Pandemic

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
Nov 7, 2023
Registry last updated
Nov 7, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.